Clinical Trial

Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia

Study acronym: HyBla_RCT
Recruiting
View on ClinicalTrials.gov →
Summary
Analysis of the efficacy and the compatibility of deep regional hyperthermia in combination with radiotherapy and chemoradiotherapy in bladder cancer
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-05-25.
Trial Details
NCT Number NCT05397262
Lead Sponsor University of Erlangen-Nürnberg Medical School
Conditions Bladder Cancer
Enrollment 1,000 participants
Start Date 2017-03-29
Primary Completion 2098-12-31 (estimated)
Study Completion 2099-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-09